Related Experiment Videos
Parity and pituitary adenoma risk
P F Coogan1, J A Baron, M Lambe
1Department of Epidemiology and Biostatistics, Boston University School of Public Health, MA 02118-2394, USA.
Journal of the National Cancer Institute
|September 20, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: A population-based study.
The Lancet regional health. Europe·2021
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.
Breast cancer research and treatment·2018
Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
The British journal of dermatology·2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
International journal of cancer·2018
The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark.
Alimentary pharmacology & therapeutics·2015
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Journal of the National Cancer Institute·2026
Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.
Journal of the National Cancer Institute·2026
Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.
Journal of the National Cancer Institute·2026
Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.
Journal of the National Cancer Institute·2026
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.
Journal of the National Cancer Institute·2026
Examining the role of extrachromosomal DNA in lung cancer.
Journal of the National Cancer Institute·2026